Sino Medical Sciences Technology Inc. (SHA:688108)
China
· Delayed Price · Currency is CNY 21.00
+0.40 (1.94%)
Apr 29, 2026, 3:00 PM CST
SHA:688108 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | 47.29 | 1.5 | -39.63 | -162.38 | -130.77 | Upgrade
|
| Depreciation & Amortization | 73.99 | 78.16 | 62.81 | 63.17 | 65.41 | Upgrade
|
| Other Amortization | 19.77 | 24.39 | 24.55 | 24.11 | 15.48 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.29 | 1.41 | -0 | -0.19 | Upgrade
|
| Asset Writedown & Restructuring Costs | 0.07 | 0.09 | 0.14 | 2.22 | 0.08 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -11.19 | 4.67 | 4.11 | 0.29 | Upgrade
|
| Provision & Write-off of Bad Debts | 0.27 | -0.43 | -1.41 | 1.33 | -0.54 | Upgrade
|
| Other Operating Activities | 10.77 | 18.47 | 5.37 | 6.78 | 11.62 | Upgrade
|
| Change in Accounts Receivable | -16.59 | 10.31 | 18.86 | 7.73 | 100.12 | Upgrade
|
| Change in Inventory | 4.14 | 18.7 | -14.53 | -18.38 | -27.79 | Upgrade
|
| Change in Accounts Payable | 0.21 | 0.34 | 3.03 | 8.04 | -59.48 | Upgrade
|
| Change in Other Net Operating Assets | 0.99 | 3.27 | 7.62 | - | - | Upgrade
|
| Operating Cash Flow | 161.87 | 131.24 | 56.84 | -111.31 | -60.13 | Upgrade
|
| Operating Cash Flow Growth | 23.34% | 130.89% | - | - | - | Upgrade
|
| Capital Expenditures | -45.8 | -70.02 | -67.67 | -110.76 | -158.45 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.03 | 0.83 | 1.39 | 0.02 | 0.66 | Upgrade
|
| Cash Acquisitions | - | -20.35 | -127.05 | - | -25.84 | Upgrade
|
| Investment in Securities | - | - | - | 21.19 | -5 | Upgrade
|
| Other Investing Activities | - | 0.07 | 0.29 | 0.62 | 2.04 | Upgrade
|
| Investing Cash Flow | -45.77 | -89.46 | -193.04 | -88.93 | -186.59 | Upgrade
|
| Short-Term Debt Issued | - | - | - | 55.5 | 5 | Upgrade
|
| Long-Term Debt Issued | 67.4 | 81 | 159.5 | - | - | Upgrade
|
| Total Debt Issued | 67.4 | 81 | 159.5 | 55.5 | 5 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -25 | - | Upgrade
|
| Long-Term Debt Repaid | -119.4 | -93.79 | -44.68 | -16.2 | -14.4 | Upgrade
|
| Total Debt Repaid | -119.4 | -93.79 | -44.68 | -41.2 | -14.4 | Upgrade
|
| Net Debt Issued (Repaid) | -52 | -12.79 | 114.82 | 14.3 | -9.4 | Upgrade
|
| Issuance of Common Stock | 11.53 | 15.38 | - | 103.5 | - | Upgrade
|
| Common Dividends Paid | -4.19 | -4.11 | -2.01 | -0.94 | -0.03 | Upgrade
|
| Other Financing Activities | 34.91 | 62.99 | 9.5 | - | - | Upgrade
|
| Financing Cash Flow | -9.74 | 61.47 | 122.32 | 116.86 | -9.43 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.64 | -0.21 | -0.9 | -0.95 | -0.75 | Upgrade
|
| Net Cash Flow | 104.73 | 103.03 | -14.78 | -84.33 | -256.91 | Upgrade
|
| Free Cash Flow | 116.07 | 61.22 | -10.83 | -222.07 | -218.58 | Upgrade
|
| Free Cash Flow Growth | 89.59% | - | - | - | - | Upgrade
|
| Free Cash Flow Margin | 22.09% | 13.35% | -3.16% | -115.15% | -112.46% | Upgrade
|
| Free Cash Flow Per Share | 0.27 | 0.16 | -0.03 | -0.55 | -0.54 | Upgrade
|
| Cash Income Tax Paid | 53.15 | 29.68 | 22.67 | -3.27 | 1.14 | Upgrade
|
| Levered Free Cash Flow | 81.95 | 95.15 | -29.66 | -162.62 | -163.59 | Upgrade
|
| Unlevered Free Cash Flow | 85.1 | 98.66 | -27.31 | -161.02 | -162.22 | Upgrade
|
| Change in Working Capital | 9.71 | 20.55 | -1.07 | -50.64 | -21.52 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.